These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 38184016)
21. Miniaturized nebulization catheters: a new approach for delivery of defined aerosol doses to the rat lung. Tronde A; Baran G; Eirefelt S; Lennernäs H; Bengtsson UH J Aerosol Med; 2002; 15(3):283-96. PubMed ID: 12396416 [TBL] [Abstract][Full Text] [Related]
22. Aerosol deposition in equine lungs following ultrasonic nebulisation versus jet aerosol delivery system. Votion D; Ghafir Y; Munsters K; Duvivier DH; Art T; Lekeux P Equine Vet J; 1997 Sep; 29(5):388-93. PubMed ID: 9306067 [TBL] [Abstract][Full Text] [Related]
23. Quantitative morphometric analysis of pulmonary deposition of aerosol particles inhaled via intratracheal nebulization, intratracheal instillation or nose-only inhalation in rats. Leong BK; Coombs JK; Sabaitis CP; Rop DA; Aaron CS J Appl Toxicol; 1998; 18(2):149-60. PubMed ID: 9570698 [TBL] [Abstract][Full Text] [Related]
24. Performance Comparisons of Jet and Mesh Nebulizers Using Different Interfaces in Simulated Spontaneously Breathing Adults and Children. Ari A; de Andrade AD; Sheard M; AlHamad B; Fink JB J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):281-9. PubMed ID: 25493535 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of nose-only aerosol inhalation chamber and comparison of experimental results with mathematical simulation of aerosol deposition in mouse lungs. Nadithe V; Rahamatalla M; Finlay WH; Mercer JR; Samuel J J Pharm Sci; 2003 May; 92(5):1066-76. PubMed ID: 12712427 [TBL] [Abstract][Full Text] [Related]
26. Lung Deposition of Alpha1-Proteinase Inhibitor (Human) (A1-PI[H]) Inhalation Solution Using Two Inhalation Modes of the I-neb Adaptive Aerosol Delivery (AAD) System in Healthy Subjects and Subjects with Cystic Fibrosis. Häussermann S; Winnips C; Edelman J; Kappeler D; Herpich C; Ehlich H; Zanker D; Kietzig C; Sommerer K J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):242-50. PubMed ID: 26669827 [TBL] [Abstract][Full Text] [Related]
27. The function and performance of aqueous aerosol devices for inhalation therapy. Carvalho TC; McConville JT J Pharm Pharmacol; 2016 May; 68(5):556-78. PubMed ID: 27061412 [TBL] [Abstract][Full Text] [Related]
28. Intermittent aerosol delivery to the lungs during high-flow nasal cannula therapy. Golshahi L; Longest PW; Azimi M; Syed A; Hindle M Respir Care; 2014 Oct; 59(10):1476-86. PubMed ID: 24917454 [TBL] [Abstract][Full Text] [Related]
29. Effect of nebulizer type, delivery interface, and flow rate on aerosol drug delivery to spontaneously breathing pediatric and infant lung models. Ari A Pediatr Pulmonol; 2019 Nov; 54(11):1735-1741. PubMed ID: 31313534 [TBL] [Abstract][Full Text] [Related]
30. Development of a size-dependent aerosol deposition model utilising human airway epithelial cells for evaluating aerosol drug delivery. Cooney D; Kazantseva M; Hickey AJ Altern Lab Anim; 2004 Dec; 32(6):581-90. PubMed ID: 15757496 [TBL] [Abstract][Full Text] [Related]
31. Fabrication, characterization and optimization of nanostructured lipid carrier formulations using Beclomethasone dipropionate for pulmonary drug delivery via medical nebulizers. Khan I; Hussein S; Houacine C; Khan Sadozai S; Islam Y; Bnyan R; Elhissi A; Yousaf S Int J Pharm; 2021 Apr; 598():120376. PubMed ID: 33617949 [TBL] [Abstract][Full Text] [Related]
32. Aerosolized protein delivery in asthma: gamma camera analysis of regional deposition and perfusion. Sangwan S; Agosti JM; Bauer LA; Otulana BA; Morishige RJ; Cipolla DC; Blanchard JD; Smaldone GC J Aerosol Med; 2001; 14(2):185-95. PubMed ID: 11681650 [TBL] [Abstract][Full Text] [Related]
33. Inhaled aerosol dose distribution between proximal bronchi and lung periphery. Verbanck S; Biddiscombe MF; Usmani OS Eur J Pharm Biopharm; 2020 Jul; 152():18-22. PubMed ID: 32361031 [TBL] [Abstract][Full Text] [Related]
34. Aerosol delivery during spontaneous breathing with different types of nebulizers- in vitro/ex vivo models evaluation. Lin HL; Fang TP; Cho HS; Wan GH; Hsieh MJ; Fink JB Pulm Pharmacol Ther; 2018 Feb; 48():225-231. PubMed ID: 29277689 [TBL] [Abstract][Full Text] [Related]
35. Comparative Study on the Size Distributions, Respiratory Deposition, and Transport of Particles Generated from Commonly Used Medical Nebulizers. Wang Y; Li J; Leavey A; O'Neil C; Babcock HM; Biswas P J Aerosol Med Pulm Drug Deliv; 2017 Apr; 30(2):132-140. PubMed ID: 27977321 [TBL] [Abstract][Full Text] [Related]
36. Present Situation and Future Progress of Inhaled Lung Cancer Therapy: Necessity of Inhaled Formulations with Drug Delivery Functions. Okuda T; Okamoto H Chem Pharm Bull (Tokyo); 2020; 68(7):589-602. PubMed ID: 32611996 [TBL] [Abstract][Full Text] [Related]
37. [Can mesh nebulizers improve prehospital aerosol therapy? An in vitro study on simulated prehospital emergency patients suffering from respiratory distress]. Otto M; Kropp Y; Kummer L; Thiel M; Tsagogiorgas C Anaesthesiologie; 2022 Oct; 71(10):758-766. PubMed ID: 35976418 [TBL] [Abstract][Full Text] [Related]
38. Nebulizer-compatible liquid formulations for aerosol pulmonary delivery of hydrophobic drugs: glucocorticoids and cyclosporine. Klyashchitsky BA; Owen AJ J Drug Target; 1999; 7(2):79-99. PubMed ID: 10617295 [TBL] [Abstract][Full Text] [Related]
39. Nasally inhaled pulsating aerosols: lung, sinus and nose deposition. Moller W; Saba GK; Haussinger K; Becker S; Keller M; Schuschnig U Rhinology; 2011 Aug; 49(3):286-91. PubMed ID: 21858257 [TBL] [Abstract][Full Text] [Related]
40. Optimized aerosol delivery to a mechanically ventilated rodent. MacLoughlin RJ; Higgins BD; Laffey JG; O'Brien T J Aerosol Med Pulm Drug Deliv; 2009 Dec; 22(4):323-32. PubMed ID: 19415985 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]